CN103054937A - Medicament for treating bronchus asthma - Google Patents

Medicament for treating bronchus asthma Download PDF

Info

Publication number
CN103054937A
CN103054937A CN2012105242173A CN201210524217A CN103054937A CN 103054937 A CN103054937 A CN 103054937A CN 2012105242173 A CN2012105242173 A CN 2012105242173A CN 201210524217 A CN201210524217 A CN 201210524217A CN 103054937 A CN103054937 A CN 103054937A
Authority
CN
China
Prior art keywords
grams
medicament
asthma
radix
flos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105242173A
Other languages
Chinese (zh)
Inventor
高慧芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012105242173A priority Critical patent/CN103054937A/en
Publication of CN103054937A publication Critical patent/CN103054937A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A medicament for treating bronchus asthma belongs to the technical field of medical preparation. The invention adopts a technical scheme that the medicament is composed of the components containing following effective composition ranges: 3-9 grams of inula flower, 3-9 grams of Virginia snakeroot, 3-9 grams of dahurian angelica root, 2-9 grams of licorice, 3-9 grams of coltsfoot flower, 3-9 grams of globe amaranth, 3-9 grams of aster root and 2-6 grams of american ginseng. The medicament can relieve spasm and asthma, resist allergy, alleviate mucosal edema, promote discharge of phlegm, enhance body resistance and comprehensively treat the bronchus asthma.

Description

A kind of medicine for the treatment of bronchial asthma
Technical field: the invention belongs to the medicinal preparation technical field, is a kind of medicine for the treatment of bronchial asthma specifically.
Background technology: bronchial asthma is a kind of anaphylactic disease of respiratory system, the patient is subject to the stimulation of various factors or when contacting with anaphylactogen, will cause tracheole smooth muscle contraction, mucosa edema and mucous secretion to increase, so that air flue spasm, narrow, and dyspnea appears, traditional Therapeutic Method adopts the folk prescription curative effect of medication undesirable, has increased work difficulty to the medical worker.
Summary of the invention: the purpose of this invention is to provide a kind of medicine for the treatment of bronchial asthma that can solve the prior art deficiency.
The present invention adopts following technical scheme.Every part by the ingredients that contains following active princlple scope:
Flos Inulae 3-9 gram; Fructus Aristolochiae 3-9 gram; Radix Angelicae Dahuricae 3-9 gram; Radix Glycyrrhizae 2-9 gram; Flos Farfarae 3-9 gram; Flos Gomphrenae 3-9 gram; Radix Asteris 3-9 gram; Radix Panacis Quinquefolii 2-6 gram.
Every part of the present invention can be by the ingredients that contains following active component:
Flos Inulae 9 grams; Fructus Aristolochiae 9 grams; The Radix Angelicae Dahuricae 6 grams; Radix Glycyrrhizae 6 grams; Flos Farfarae 6 grams; Flos Gomphrenae 6 grams; Radix Asteris 6 grams; Radix Panacis Quinquefolii 5 grams.
The present invention is mainly by Flos Inulae, Fructus Aristolochiae, the Radix Angelicae Dahuricae, Radix Glycyrrhizae, Flos Farfarae, Flos Gomphrenae, Radix Asteris, Radix Panacis Quinquefolii.Flos Inulae expectorant row water, the sending down the abnormal ascending QI preventing or arresting vomiting.Contain flavonoid glycoside, bronchospasm is had mitigation, and can relaxing smooth muscle.Fructus Aristolochiae lung heat clearing sending down the abnormal ascending QI, relieving cough and asthma.Contain Aristolochic Acid, aristolo chine etc., can eliminate the phlegm, alleviate bronchospasm, golden Portugal bacterium, streptococcus pneumoniae are had inhibitory action.Radix Angelicae Dahuricae expelling pathogenic wind from the body surface, logical hair key, the dampness detoxifcation.Can reduce the bronchial secretion expansion, coronary artery dilator.The Radix Glycyrrhizae heat-clearing and toxic substances removing, the mediation property of medicine, expelling phlegm for arresting cough.Contained glycyrrhizin is hydrolyzed to enoxolone in vivo, and the inflammation-inhibiting of similar adrenocortical hormone and mineralocorticoid is arranged, and anti-allergic effects has the maincenter antitussive effect, and bronchial mucosa is had protective effect.Flos Farfarae nourishing the lung to keep the adverse QI downward, relieving cough and resolving phlegm.Contain faradiol, arnica montana glycol, Saponin and volatile oil, can remove the bronchospasm that causes because of histamine.Flos Gomphrenae expelling wind and clearing away heat relieving cough and asthma.Can suppress bronchial muscular spasm, the effect of have preferably spasmolytic, cough-relieving, eliminating the phlegm, relievining asthma.The Radix Asteris preventing phlegm from forming and stopping coughing can increase respiratory tract glandular secretion , pig and release sputum, is easy to expectoration.Radix Panacis Quinquefolii is the first-selected medical material of QI invigorating, can promote that serum albumin is synthetic, bone marrow protein is synthetic, improves the resistance of body.
Said components forms the comprehensive pharmacological action of medicine, so that the present invention has significant technique effect and advantage, can spasmolytic relieving asthma, antiallergic, alleviate mucosa edema, promote sputum to discharge the enhancing body resistance, bronchial asthma is carried out comprehensive comprehensive treatment, and effect is remarkable.
Through clinical observation, these side's treatment 30 routine patients, clinical total effective rate reaches 87%, has very high promotional value.
The specific embodiment: a kind of medicine for the treatment of bronchial asthma, every part by the ingredients that contains following active component:
Flos Inulae 9 grams; Fructus Aristolochiae 9 grams; The Radix Angelicae Dahuricae 6 grams; Radix Glycyrrhizae 6 grams; Flos Farfarae 6 grams; Flos Gomphrenae 6 grams; Radix Asteris 6 grams; Radix Panacis Quinquefolii 5 grams.
With said medicine enter decoction fried after, a potion gets final product for twice on the one.

Claims (1)

1. medicine for the treatment of bronchial asthma, Flos Inulae 9 grams; Fructus Aristolochiae 9 grams; The Radix Angelicae Dahuricae 6 grams; Radix Glycyrrhizae 6 grams; Flos Farfarae 6 grams; Flos Gomphrenae 6 grams; Radix Asteris 6 grams; Radix Panacis Quinquefolii 5 grams.
CN2012105242173A 2012-11-28 2012-11-28 Medicament for treating bronchus asthma Pending CN103054937A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012105242173A CN103054937A (en) 2012-11-28 2012-11-28 Medicament for treating bronchus asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012105242173A CN103054937A (en) 2012-11-28 2012-11-28 Medicament for treating bronchus asthma

Publications (1)

Publication Number Publication Date
CN103054937A true CN103054937A (en) 2013-04-24

Family

ID=48098032

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012105242173A Pending CN103054937A (en) 2012-11-28 2012-11-28 Medicament for treating bronchus asthma

Country Status (1)

Country Link
CN (1) CN103054937A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893737A (en) * 2014-04-23 2014-07-02 王林 Medicament used for treating bronchial asthma and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299665A (en) * 1998-12-16 2001-06-20 李才 Shuangqi lung-protecting allergy-eliminating instant powder
CN1583124A (en) * 2004-06-11 2005-02-23 北京同仁堂股份有限公司 Preparation of pills by pressing process
CN101019906A (en) * 2007-03-19 2007-08-22 沈信堂 Chinese medicine for relieving cough, eliminating phlegm and relieving asthma
CN101502623A (en) * 2009-01-09 2009-08-12 常为民 Quality control method of tracheitis pill preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299665A (en) * 1998-12-16 2001-06-20 李才 Shuangqi lung-protecting allergy-eliminating instant powder
CN1583124A (en) * 2004-06-11 2005-02-23 北京同仁堂股份有限公司 Preparation of pills by pressing process
CN101019906A (en) * 2007-03-19 2007-08-22 沈信堂 Chinese medicine for relieving cough, eliminating phlegm and relieving asthma
CN101502623A (en) * 2009-01-09 2009-08-12 常为民 Quality control method of tracheitis pill preparation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《姚冬琴; 张的凤; 张金莲;》: "《马兜铃肾病的研究》", <江西中医药> *
20101231 《姚冬琴; 张的凤; 张金莲;》 《马兜铃肾病的研究》 , *
国家食品药品监督管理局: "《国家药品食品监督管理总局网站》", 5 August 2004 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893737A (en) * 2014-04-23 2014-07-02 王林 Medicament used for treating bronchial asthma and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102091191B (en) Medicament for treating chronic pharyngitis
CN102475863A (en) Chinese medicine for treating chronic bronchitis
CN102641394B (en) Traditional Chinese medicine composite for treating allergic rhinitis
CN105288406A (en) Traditional Chinese medicine preparation for treating bronchitis due to deficiency of both lung and spleen as well as preparation method thereof
CN104288477A (en) Traditional Chinese medicine preparation curing infantile asthma
CN103054937A (en) Medicament for treating bronchus asthma
CN104027788A (en) Traditional Chinese medicine composition for treating exogenous cold
CN103908589B (en) Plaster for treating cold
CN102949509A (en) Pure traditional Chinese medical health protection syrup for clearing lung heat and stopping cough and preparation method thereof
CN103585451A (en) Traditional Chinese medicine for treating children allergic rhinitis
CN103977234A (en) Pseudostellaria root cough-relieving and asthma-calming traditional Chinese medicine preparation
CN102920822A (en) Pyriformis syndrome treatment prescription
CN103536673B (en) Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof
CN102727733B (en) Traditional Chinese medicine used for treating chronic bronchitis
CN102727614B (en) Chinese-western medicine preparation for treating chronic obstructive pulmonary disease
CN102824522B (en) Medicine for treating infectious pneumonia and preparation method thereof
CN105362548A (en) Traditional Chinese medicine for treating allergic asthma
CN104800598A (en) Traditional Chinese medicine for treating pharyngitis
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN104435636B (en) A kind of Chinese medicine composition for preventing paracmasis chronic bronchitis to recur
CN104587241A (en) Traditional Chinese medicine composition for treating acute tracheitis
CN103830534A (en) Chinese medicinal composition for treating chronic bronchitis
CN103372185A (en) Medicine for treating chronic bronchitis
CN103417823A (en) Traditional Chinese medicine for treating hyperthyroidism
CN102716290B (en) Traditional Chinese medicine for treating bronchial asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130424